Drug profile

The FDA adverse-event record for Cortisone Inj

Name: Cortisone Inj - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

52 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Cortisone Inj. Species, reactions, and outcomes follow.

#1090 of 2,679
by report volume (all drugs): 52
adverse-event reports: 5.8%
death-coded share: Dog
most-reported species

Compiled by PlainBreed

Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Cortisone Inj ranks #1088 of 2679 by total reports (52) and #747 of 1130 by death-coded share (5.8%). National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1): 97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1): #1088
This drug, reports of 2679: #747
This drug, death share of 1130

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Cortisone Inj has 52 reports now versus 52 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: +0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Cortisone Inj changes

Signature read: Cortisone Inj's 5.8% death-coded share is among the lowest in the openFDA drug corpus.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

5.8%

Death-coded share of reports

Active Ingredients

Cortisone Inj

Administration Routes

UnknownParenteralSubcutaneousIntramuscular

Species Affected

Dog 37

Cat 15

Most Affected Breeds

Domestic Shorthair 8

Chihuahua 5

Bichon Frise 3

Shih Tzu 3

Dog (other) 2

Terrier - Jack Russell 2

Pit Bull 2

Crossbred Canine/dog 2

Domestic Longhair 2

Retriever - Labrador 2

Most Reported Reactions

Emesis 13

Lack of efficacy (ectoparasite) - flea 12

Lethargy (see also Central nervous system depression in 'Neurological') 11

Vomiting 10

Behavioural disorder NOS 8

Decreased appetite 4

Lack of efficacy - NOS 3

Panting 3

Other abnormal test result NOS 3

UNPALATABLE 3

Hair loss NOS 3

Ataxia 2

Outcome Breakdown

Recovered/Normal

23 (44.2%)

Outcome Unknown

20 (38.5%)

Recovered with Sequela

3 (5.8%)

Ongoing

3 (5.8%)

Euthanized

2 (3.8%)

Died

1 (1.9%)

Cortisone Inj: low death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Nationwide drugs with similar profiles

Two openFDA-derived peer sets for Cortisone Inj, both floored at ≥50 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other drugs by FDA report count (52 here).

Bacitracin + Neomycin + Polymyxin B 52 Chemotherapy Drug 52 Dexmedetomidine (Unknown) 52 Fatty Acid Supplement 52

Similar death-coded share

Nearest other drugs by death-coded share (5.8% here), distinct from the volume row.

Pyrantel Embonate, Praziquantel 5.8% Oxybendazole 5.8% Trifexis 5.7% Avocado/Soybean Unsaponifiable + Glucosamine + Sodium Chondroitin Sulfate 5.8%

What to do with this drug

Compare Cortisone Inj's report volume and death-coded share against similar drugs nationwide. See similar drugs
Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full drug directory to compare report counts across products. All drugs

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Cortisone Inj (#1090 of 2,679 by report volume); death-coded 5.8%. PlainBreed drug row · death-coded share stamp 5.8% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →